Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Sermorelin Alternatives 2026 Best: GHRH vs GHRP Comparison

Before selecting a sermorelin alternative, understand how GHRH analogues and GHRPs differ mechanistically and what that means for your research endpoints. Receptor Target GHRH receptor Ghrelin receptor (GHSR-1a) GHRPs bypass somatostatin inhibition that limits

This comparison does not assign a generated winner or score.

  • Before selecting a sermorelin alternative, understand how GHRH analogues and GHRPs differ mechanistically and what that means for your research endpoints.
  • Receptor Target
  • GHRH receptor
  • Ghrelin receptor (GHSR-1a)
  • GHRPs bypass somatostatin inhibition that limits GHRH analogues
  • Plasma Half-Life
  • 8–12 minutes
  • 6–8 days
  • ~2 hours
  • ~1.5 hours
  • 4–6 hours
  • CJC-1295 DAC and MK-677 enable once-daily or less frequent dosing
  • Dosing Frequency
  • 2–3x daily
  • 1–2x weekly
  • 1–3x daily
  • 2–3x weekly (pulsed)
  • 1x daily
  • Longer half-lives reduce protocol complexity but may obscure pulsatility
  • Peak GH Amplitude
  • Moderate
  • Moderate-low
  • Moderate-high
  • Very high
  • Hexarelin produces highest peaks; CJC-1295 produces highest sustained AUC
  • Cortisol/Prolactin
  • Minimal
  • Moderate elevation
  • Ipamorelin and MK-677 offer cleanest GH selectivity for metabolic studies
  • Desensitization Risk
  • Low
  • Very low
  • High (chronic use)
  • Hexarelin requires pulsed dosing; others tolerate continuous administration